(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company
developing innovative drug candidates for the prevention and treatment of cancer, today announced that its Chief Scientific Officer, Dr. Heman Chao, has been invited to give an oral presentation at the 2015 Joint Conference of the Canadian Society For Pharmaceutical Science and the Canadian Chapter of the Controlled Release Society.
- 0 Comments
- FY2015